Company Profile
Sandoo Pharmaceuticals and Chemcials Co.,Ltd was established in 2009, with a young and active team, located in Ningbo, China. Specializes in exporting and importing pharmaceutical intermediates and chemical products as well as active pharmaceutical ingredients. Sandoo is always modest, learn and become experienced in pharmaceutical industry. As experienced trader, develop and get support from China-based but exporting-oriented manufacturers. With various valuable sources, serve our clients in professional way. To be harder, faster, stronger and better, for invaluable trust from every party. We will be armed with top R&D and brilliant plant to be an excellent role in pharmaceutical field. Be your indispensable and valuable partner.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
((2R,3R,4R)-3-(benzoyloxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl benzoate |
D-erythro-Pentonic acid,2-deoxy-2-fluoro-2-methyl-,γ-lactone,3,5-dibenzoate,(2R)-;(2R)-2-Deoxy-2-fluoro-2-methyl-D-erythro-pentonic acid γ-lactone 3,5-dibenzoate;1033394-81-8 |
874638-80-9 | Inquiry | |
((5-Thiazolyl)methyl)-(4-nitrophenyl)carbonate hydrochloride |
Carbonic acid,4-nitrophenyl 5-thiazolylmethyl ester,hydrochloride (1:1);Carbonic acid,4-nitrophenyl 5-thiazolylmethyl ester,monohydrochloride;5-(p-Nitrophenyloxycarbonyloxymethyl)thiazole hydrochloride |
154212-59-6 | Inquiry | |
(1R,2R)-(-)-1,2-Cyclohexanedicarboxylic Acid |
46022-05-3 | Inquiry | ||
(1R,2R)-1,2-Cyclohexanedimethanol |
Lurasidone INT 3;[(1R,2R)-2-(hydroxymethyl)cyclohexyl]methanol;(1R,2R)-1,2-CYCLOHEXANEDI;(1R,2R)-1,2-Cyclohexanedimethanol;(1R,2R)-1,2-CYCLOHEXANEDIMETHANOL;(1R,2R)-cyclohexane-1,2-diyldimethanol;(1R,2R)-1,2-Bis(hydroxymethyl)cyclohexane;1,2-CyclohexanediMethanol, (1R,2R)- |
65376-05-8 | Inquiry | |
(1R,3S,4S)-3-(6-Bromo-1H-benzimidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-dimethylethyl ester |
2-Azabicyclo[2.2.1]heptane-2-carboxylic acid,3-(6-bromo-1H-benzimidazol-2-yl)-,1,1-dimethylethyl ester,(1R,3S,4S)-;1,1-Dimethylethyl (1R,3S,4S)-3-(6-bromo-1H-benzimidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate |
1256387-74-2 | Inquiry | |
(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride |
Bicyclo[4.2.0]octa-1,3,5-triene-7-methanamine,3,4-dimethoxy-N-methyl-,hydrochloride (1:1),(7S)-;Bicyclo[4.2.0]octa-1,3,5-triene-7-methanamine,3,4-dimethoxy-N-methyl-,hydrochloride,(7S)-;(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride;(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride;(S)-N-[(4,5-Dimethoxybenzocyclobutan-1-yl)methyl]-N-methylamine hydrochloride |
866783-13-3 | Inquiry | |
(2R)-2-Deoxy-2-fluoro-2-methyluridine |
Uridine,2′-deoxy-2′-fluoro-2′-methyl-,(2′R)-;(2′R)-2′-Deoxy-2′-fluoro-2′-methyluridine;RO 2433;PSI-6206;GS 331007;1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione;(2′R)-2′-Deoxy-2′-fluoro-2′-methyluridine |
863329-66-2 | Inquiry | |
(2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahyd |
Cyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxamide,N-(cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxo-,(2R,3aR,10Z,11aS,12aR,14aR)-;(2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxamide;TMC 435350;TMC 435;Simeprevir;Sovriad;Olysio;Merospevir |
923604-59-5 | Inquiry | |
(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione |
14805-29-9 | Inquiry | ||
(3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one |
D-Gluconic acid,2,3,4,6-tetrakis-O-(trimethylsilyl)-,δ-lactone;Gluconic acid,2,3,4,6-tetrakis-O-(trimethylsilyl)-,δ-lactone,D-;2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone;(3R,4S,5R,6R)-3,4,5-Tris[(trimethylsilyl)oxy]-6-[[(trimethylsilyl)oxy]methyl]tetrahydropyran-2-one;(3R,4S,5R,6R)-3,4,5-Tri[(trimethylsilyl)oxy]-6-[[(trimethylsilyl)oxy]methyl]tetrahydro-2H-pyran-2-one;(3R,4S,5R,6R)-3,4,5-Tris(trimethylsilyloxy)-6-[(trimethylsilyloxy)methyl]tetrahydro-2H-pyran-2-one;2,3,4,6-Tetra-O-(trimethylsilyl)-D-glucono-1,5-lactone;55515-29-2 |
32384-65-9 | Inquiry | |
(4-hydrazinylphthalazin-1-yl)hydrazine,sulfuric acid |
Phthalazine,1,4-dihydrazinyl-,sulfate (1:1);Phthalazine,1,4-dihydrazino-,sulfate (1:1);1,4-Phthalazinedione,2,3-dihydro-,dihydrazone,sulfate (1:1);Depressan;1,4-Dihydrazinophthalazine sulfate;Dihydrazinophthalazine sulfate;Dihydralazine sulfate;Dihyzin |
7327-87-9 | Inquiry | |
(4R,12aS)-N-(2,4-difluorobenzyl)-7-benzylhydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
(4R,12aS)-N-(2,4-difluorobenzyl)-7-benzylhydroxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxaMide;(4R,12aS)-7-(benzyloxy)-N-(2,4-difluorobenzyl)-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxaMide;(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-4-methyl-6,8-dioxo-7-(phenylmethoxy)-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide;Dolutegravir Intermediate4;(4R,12aS)-7-(benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide;3 4 6-TRICHLOROBENZYL ALCOHOL 97;2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-4-methyl-6,8-dioxo-7-(phenylmethoxy)-, (4R,12aS)- |
1206102-11-5 | Inquiry | |
(5-broMo-2-Methylphenyl)(5-(4-fluorophenyl)thiophen-2-yl)Methanone |
1132832-75-7 | Inquiry | ||
(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester |
D-threo-Pentitol,2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-1-(1H-1,2,4-triazol-1-yl)-;2,5-Anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol |
149809-43-8 | Inquiry | |
(8a,9R)-Cinchonan-9-ol mono[[(S)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetate] |
Cinchonan-9-ol,(8α,9R)-,mono[[(S)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetate] (salt);Cinchonan-9-ol,(8α,9R)-,mono[[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]acetate] (salt);Acetic acid,[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]-,[R-(R*,S*)]-,compd. with (8α,9R)-cinchonan-9-ol (1:1);Acetic acid,[(S)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]-,compd. with (8α,9R)-cinchonan-9-ol (1:1) |
137590-32-0 | Inquiry | |
(R)-(-)-3-Carbamoymethyl-5-methylhexanoic acid |
(r)-(-)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid;(r)-(-)-3-carbamoymethyl-5-methylhexanoic acid;INTERMEDIATE OF PREGABALIN;(3R)-3-(2-AMino-2-oxoethyl)-5-Methylhexanoic Acid;(R)-3-(2-AMINO-2-OXOETHYL)-5-METHYLHEXANOIC ACID:99+%;3-CarbaMoyl Mehyl-5-Methyl Hexanoic Acid;Pregabalin IMpurity III;Hexanoic acid,3-(2-aMino-2-oxoethyl)-5-Methyl-,(3R)- |
181289-33-8 | Inquiry | |
(R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine |
2-Pyridinamine,5-bromo-3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-;5-Bromo-3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-2-pyridinamine;[5-Bromo-3-[1(R)-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-yl]amine;[5-Bromo-3-[[(R)-1-(2,6-dichloro-3-fluorophenyl)ethyl]oxy]pyridin-2-yl]amine;(R)-5-Bromo-3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-amine;(R)-5-Bromo-3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-amine;1421926-42-2 |
877399-00-3 | Inquiry | |
(S)-3,3-Dimethyl-2-((1R,2R)-2-pent-4-ynyl-cyclopropoxycarbonylamino)-butyric acid, tert-butylamine salt |
(S)-3,3-Dimethyl-2-((1R,2R)-2-pent-4-ynyl-cyclopropoxycarbonylamino)-butyric acid, tert-butylamine salt;Alkyne Acid t-butylamine;3-Methyl-N-[[[(1R,2R)-2-(4-pentyn-1-yl)cyclopropyl]oxy]carbonyl]-L-valine compd. with 2-methyl-2-propanamine;(S)-3,3-Dimethyl-2-((((1R,2R)-2-(pent-4-yn-1-yl)cyclopropoxy)carbonyl)amino)butyric acid tert-butylamine salt;MK-5172 Intermediate 2;EOS-61020 |
1425038-21-6 | Inquiry | |
(S)-5-Boc-5-Azaspiro[2.4]heptane-6-carboxylic acid |
(S)-5-(tert-Butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid;(6S)-5-[(tert-butoxy)carbonyl]-5-azaspiro[2.4]heptane-6-carboxylic acid;(6S)-5-(TERT-BUTOXYCARBONYL)-5-AZASPIRO[2.4]HEPTANE-6-CARBOXYLIC ACID;(S)-5-BOC-5-AZASPIRO[2.4]HEPTANE-6-CARBOXYLIC ACID;(5S)-6-tert-butoxycarbonyl-6-azaspiro[2.4]heptane-5-carboxylic acid;(6S)-5-[(2-methylpropan-2-yl)oxycarbonyl]-5-azaspiro[2.4]heptane-6-carboxylic acid;MFCD11099673;(s)-5-(tert-butoxycarbonyl)-5-azaspiro(2.4)heptane-6-carboxylic acid;(6R)-5-[(tert-butoxy)carbonyl]-5-azaspiro[2.4]heptane-6-carboxylic acid;SCHEMBL193274 |
1129634-44-1 | Inquiry | |
(S)-Glycidyl 3-Nitrobenzenesulfonate |
Benzenesulfonic acid,3-nitro-,(2S)-2-oxiranylmethyl ester;Benzenesulfonic acid,3-nitro-,oxiranylmethyl ester,(S)-;Benzenesulfonic acid,3-nitro-,(2S)-oxiranylmethyl ester;(S)-Glycidyl 3-nitrobenzenesulfonate;(S)-2,3-Epoxypropyl 3-nitrobenzenesulfonate;(S)-Glycidyl m-nitrobenzenesulfonate;(S)-(+)-Gycidyl 3-nitrobenzenesulfonate;(2S)-(+)-Glycidyl 3-nitrobenzenesulfonate;(S)-(+)-3-Nitrobenzenesulfonic acid oxiranylmethyl ester;(2S)-Glycidyl 3-nitrobenzenesulfonate;(S)-(+)-Glycidyl 3-nitrobenzenesulfonate;(2S)-(+)-Glycidyl 3-nitrobenzenesulfonate;(2S)-Oxiranylmethyl 3-nitrobenzenesulfonate;((2S)-Oxiran-2-yl)methyl 3-nitrobenzenesulfonate;(S)-(2,3-Epoxypropan-1-yl) 3-nitrobenzenesulfonate;(S)-Oxiran-2-ylmethyl 3-nitrobenzenesulfonate;3-Nitrobenzenesulfonic acid (S)-oxiran-2-ylmethyl ester;3-Nitrobenzenesulfonic acid (2S)-oxiran-2-ylmethyl ester;(S)-(+)-3-Nitrobenzenesulfonic acid glycidyl ester;3-Nitrobenzenesulfonic acid (S)-glycidyl ester;(S)-3-Nitrobenzenesulfonic acid oxiranylmethyl ester;[(2S)-Oxiran-2-yl]methyl 3-nitrobenzenesulfonate;(S)-Oxiran-2-yl methyl 3-nitrobenzenesulfonate;203991-21-3 |
115314-14-2 | Inquiry |
CONTACT INFORMATION
Sign In for Details